Evidence map›Paper›PMID 33269255›Full record

ArticleWorld journal of clinical cases2020

Epidemiological and clinical characteristics of fifty-six cases of COVID-19 in Liaoning Province, China.

Jing-Bo Wang, Hai-Tao Wang, Lei-Shi Wang, Lu-Ping Li, Jiao Xv, Chun Xv, Xing-Hai Li, Yun-Hai Wu, Hong-Yan Liu, Bai-Jun Li and 8 more

Open access · diamondAbstract read
In one paragraph

Article in World journal of clinical cases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Jing-Bo WangDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Hai-Tao WangDepartment of General Surgery, The Second Affiliated Hospital of Shenyang Medical College, Shenyang 110002, Liaoning Province, China.
Lei-Shi WangDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Lu-Ping LiDepartment of Clinical Laboratory, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Jiao XvDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Chun XvDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Xing-Hai LiDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Yun-Hai WuDepartment of Intensive Critical Medicine, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Hong-Yan LiuDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Bai-Jun LiDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Hong YuDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Xia TianDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Zhi-Yu ZhangDepartment of Infectious Diseases Clinic, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Yan WangDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Rui ZhaoDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Jin-Yang LiuDepartment of Infectious Diseases Clinic, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Wei WangDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China.
Ye GuDepartment of Infectious Disease, The Sixth People's Hospital of Shenyang, Shenyang 110006, Liaoning Province, China. gu3311@126.com.
The Sixth People's Hospital of Shenyang · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPneumonia of uncertain cause has been reported in Wuhan, China since the beginning of early December 2019. In early January 2020, a novel strain of β-coronavirus was identified by the Chinese Center for Disease Control and Prevention from the pharyngeal swab specimens of patients, which was recently named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is evidence of human-to-human transmission and familial cluster outbreak of SARS-CoV-2 infection. The World Health Organization(WHO) recently declared the SARS-CoV-2 epidemic a global health emergency. As of February 17, 2020, 71329 laboratory-confirmed cases (in 25 countries, including the United States and Germany) have been reported globally. Other than its rapid transmission, the epidemiological and clinical characteristics of coronavirus disease 2019 (COVID-19) remain unclear. In December 2019, coronavirus disease (named COVID-19 by the WHO) associated with the SARS-CoV-2 emerged in Wuhan, China and spread quickly across the country.

aimTo analyze the epidemiological and clinical characteristics of confirmed cases of this disease in Liaoning province, a Chinese region about 1800 km north of Wuhan.

methodsThe clinical data of 56 laboratory-confirmed COVID-19 cases due to 2019-nCoV infection were analyzed. The cases originated from eight cities in Liaoning province.

resultsThe median age of the patients was 45 years, and 57.1% of them were male. No patient had been in direct contact with wild animals. Among them, 23 patients (41.1%) had resided in or traveled to Wuhan, 27 cases (48.2%) had been in contact with confirmed COVID-19 patients, 5 cases (8.9%) had been in contact with confirmed patients with a contact history to COVID-19 patients, and 1 case (1.8%) had no apparent history of exposure. Fever (75.0%) and cough (60.7%) were the most common symptoms. The typical manifestations in lung computed tomography (CT) included ground-glass opacity and patchy shadows, with 67.8% of them being bilateral. Among the patients in the cohort, 78.6% showed reduction in their lymphocyte counts, 57.1% showed increases in their C-reactive protein levels, and 50.0% showed decreases in their blood albumin levels. Eleven patients (19.6%) were admitted to intensive care unit, 2 patients (3.5%) progressed to acute respiratory distress syndrome, 4 patients (7.1%) were equipped with non-invasive mechanical ventilation, and 1 patient (1.8) received extracorporeal membrane oxygenation support. There were 5 mild cases (5/56, 8.9%), 40 moderate cases (40/56, 71.4%), 10 severe cases (10/56, 17.9%), and 1 critical case (1/56, 1.8%). No deaths were reported.

conclusionSARS-CoV-2 can be transmitted among humans. Most COVID-19 patients show symptoms of fever, cough, lymphocyte reduction, and typical lung CT manifestations. Most are moderate cases. The seriousness of the disease (as indicated by blood oxygen saturation, respiratory rate, oxygenation index, blood lymphocyte count, and lesions shown in lung CT) is related to history of living in or traveling to Wuhan, underlying diseases, admittance to intensive care unit, and mechanical ventilation.

Indexed as

Acute respiratory distress syndromeClinical characteristicsCOVID-19Epidemiological characteristicsHypoxemiaSARS-CoV-2

Identifiers

PMID33269255
PMCPMC7674744
OpenAlexW3097889267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.